Stephen Rocamboli - Net Worth and Insider Trading
Stephen Rocamboli Net Worth
The estimated net worth of Stephen Rocamboli is at least $20,108 dollars as of 2024-04-29. Stephen Rocamboli is the Director of Esperion Therapeutics Inc and owns about 8,111 shares of Esperion Therapeutics Inc (ESPR) stock worth over $15,695. Stephen Rocamboli is also the Director of TFF Pharmaceuticals Inc and owns about 1,440 shares of TFF Pharmaceuticals Inc (TFFP) stock worth over $4,414. Details can be seen in Stephen Rocamboli's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen Rocamboli has not made any transactions after 2023-08-15 and currently still holds the listed stock(s).
Transaction Summary of Stephen Rocamboli
Stephen Rocamboli Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen Rocamboli owns 3 companies in total, including TFF Pharmaceuticals Inc (TFFP) , VioQuest Pharmaceuticals Inc (VOQP) , and Esperion Therapeutics Inc (ESPR) .
Click here to see the complete history of Stephen Rocamboli’s form 4 insider trades.
Insider Ownership Summary of Stephen Rocamboli
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TFFP | TFF Pharmaceuticals Inc | 2023-08-15 | director |
| VOQP | VioQuest Pharmaceuticals Inc | 2008-06-13 | director & Secretary |
| ESPR | Esperion Therapeutics Inc | 2023-05-10 | director |
Stephen Rocamboli Latest Holdings Summary
Stephen Rocamboli currently owns a total of 2 stocks. Among these stocks, Stephen Rocamboli owns 8,111 shares of Esperion Therapeutics Inc (ESPR) as of May 10, 2023, with a value of $15,695 and a weighting of 78.05%. Stephen Rocamboli also owns 1,440 shares of TFF Pharmaceuticals Inc (TFFP) as of August 15, 2023, with a value of $4,414 and a weighting of 21.95%.
Latest Holdings of Stephen Rocamboli
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2023-05-10 | 8,111 | 1.94 | 15,695 |
| TFFP | TFF Pharmaceuticals Inc | 2023-08-15 | 1,440 | 3.07 | 4,414 |
Holding Weightings of Stephen Rocamboli
Stephen Rocamboli Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen Rocamboli has made a total of 1 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 8,111 shares on May 10, 2023, which cost Stephen Rocamboli around $12,167.
According to the SEC Form 4 filings, Stephen Rocamboli has made a total of 5 transactions in TFF Pharmaceuticals Inc (TFFP) over the past 5 years, including 3 buys and 2 sells. The most-recent trade in TFF Pharmaceuticals Inc is the acquisition of 800 shares on August 15, 2023, which cost Stephen Rocamboli around $5,000.
Insider Trading History of Stephen Rocamboli
- 1
Stephen Rocamboli Trading Performance
GuruFocus tracks the stock performance after each of Stephen Rocamboli's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen Rocamboli is -11.81%. GuruFocus also compares Stephen Rocamboli's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen Rocamboli within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen Rocamboli's insider trading performs compared to the benchmark.
Performance of Stephen Rocamboli
Average Return
-71.23%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.51 | -11.81 | -48.66 | -71.23 | ||
| Relative Return to S&P 500(%) | -5.03 | -18.86 | -57.22 | -88.84 |
Stephen Rocamboli Ownership Network
Ownership Network List of Stephen Rocamboli
Ownership Network Relation of Stephen Rocamboli
Stephen Rocamboli Owned Company Details
What does TFF Pharmaceuticals Inc do?
Who are the key executives at TFF Pharmaceuticals Inc?
Stephen Rocamboli is the director of TFF Pharmaceuticals Inc. Other key executives at TFF Pharmaceuticals Inc include 10 percent owner Carlson Capital L P , 10 percent owner Clint Duane Carlson , and 10 percent owner Double Black Diamond Offshore Ltd .
TFF Pharmaceuticals Inc (TFFP) Insider Trades Summary
Over the past 18 months, Stephen Rocamboli made 2 insider transaction in TFF Pharmaceuticals Inc (TFFP) with a net purchase of 33,000. Other recent insider transactions involving TFF Pharmaceuticals Inc (TFFP) include a net purchase of 800,000 shares made by Harlan F Weisman , a net purchase of 135,000 shares made by Zamaneh Mikhak , and a net purchase of 32,000 shares made by Kirk Allen Coleman .
In summary, during the past 3 months, insiders sold 0 shares of TFF Pharmaceuticals Inc (TFFP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,640 shares of TFF Pharmaceuticals Inc (TFFP) were sold and 44,139 shares were bought by its insiders, resulting in a net purchase of 35,499 shares.
TFF Pharmaceuticals Inc (TFFP)'s detailed insider trading history can be found in Insider Trading Tracker table.
TFF Pharmaceuticals Inc Insider Transactions
Stephen Rocamboli Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen Rocamboli. You might contact Stephen Rocamboli via mailing address: C/oparmount Capital, 787 Seventh Ave 48th Fl, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
